Opinion · 26 Jun 2024
Conference abstractPublished 25 Jun 2018
Common allergic reactions
Mediclinic City Hospital, UAE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Incidence of allergies have gone up all over the world. Drug allergies, anaphylaxis, food allergy and urticaria are the most common forms of allergic reactions and pose a clinical challenge for nurse practitioners and as well both outpatient and inpatient nurses as they encounter on day to day basis in clinical setting. As allergies are very sub specialized disease diathesis, I want to present core clinical concepts for nurse practitioners to approach the common allergic conditions with standard of care, and evidence based clinical approach for evaluation and management of them. In the current era of polypharmacy, drug allergic reactions are very common and present a great challenge for nurse practitioners. 10% of hospitalized patients may develop beta lactam drug allergy. I will present core clinical concepts based on drug allergy practice parameters update by American academy of allergy, asthma and immunology as a model to have thorough understanding on how to approach drug allergy, how to evaluate for risk assessment for future reactions, clinical approach to patients with drug allergy. Anaphyalxis is considered as killer allergy. Nurse practitioners will encounter anaphylaxis patients in both inpatient and outpatient settings. I will present updated Anaphyalxis practice parameter by AAAAI recommended evidence based clinical guidelines for evaluation and management of anaphylaxis. In incidence of food allergy has gone up by 400% in last decade, raising alarm bells. There is huge void in understanding and clinical approach to food allergy clinical evaluation and management among nurse practitioners. I will present NIAID food allergy guidelines recommended evidence based clinical approach to food allergy. 1% General population encounter chronic urticarial in their life time. For past 20 years there has been on management update for this condition beyond immunosuppressive therapy. In 2014 US FDA approved Omalizumab ( Xolair) biological therapy for management of urticarial. I will present rationale, pathophysiology and evidence for such recommendation for nurse practitioners to have better understanding and can start managing these patients in OP setting.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 30 Nov 2024
The Role of Allergic Reactions in Dermatology: Common Triggers and Treatments
Perspective · 24 Jun 2024
Common food allergens: Understanding triggers and managing allergic reactions
Editorial · 5 Jun 2017
Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy)
Research article · 21 May 2018
ANALYSIS OF CUTANEOUS ADVERSE DRUG REACTIONS ON USING COMMONLY PRESCRIBED DRUGS AT A TERTIARY CARE HOSPITAL
More from this journal
The newest in Journal of Nursing & Care.
Opinion · 29 Dec 2025
Nurses: Key to Infection Prevention and Patient Safety
Opinion · 29 Dec 2025
Holistic Nursing: Compassionate Pain Management Strategies
Perspective · 29 Dec 2025
Nursing Ethics and Legal Responsibilities: A Comprehensive Guide
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nursing & Care
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Ravi Gutta”

